The city of Santa Monica, California, currently has 1 active clinical trials seeking participants for COPD research studies.
Revefenacin in Acute Respiratory Insufficiency in COPD
Recruiting
RARICO is a pragmatic, randomized, controlled, double-blinded, multi-center trial evaluating the safety and feasibility of nebulized revefenacin in comparison to nebulized ipratropium in patients with COPD and acute respiratory failure requiring invasive mechanical ventilation.
Gender:
All
Ages:
40 years and above
Trial Updated:
12/01/2023
Locations: Santa Monica UCLA, Santa Monica, California
Conditions: COPD, Acute Respiratory Failure